Mankind Pharma plans to raise up to Rs 10,000 crore through non-convertible debentures and commercial papers. The company ...

The company's board of directors on Monday approved raising up to Rs 5,000 crore via non-convertible debentures in 3-4 ...

Mankind Pharma on Monday said it will raise up to Rs 10,000 crore via issuance of non-convertible debentures and commercial ...

Mankind Pharma's Q1 profit surged 10% YoY to ₹543 crore; brokerage Motilal Oswal expects 14% earnings CAGR over FY24-26 ...

Mankind Pharma will issue non-convertible debentures (NCDs) and commercial papers (CP) worth ₹5,000 crore. These funds will ...

Mankind Pharma plans to raise up to Rs 10,000 crore through non-convertible debentures and commercial papers. The board ...

GIFT Nifty ended 22 points or 0.08% down at 25,984.50 indicating a negative opening for domestic indices NSE Nifty 50 and BSE ...

The company will raise up to Rs 5,000 crore through non-convertible debentures (NCDs) maturing in up to 48 months, according ...

Mankind Pharma Limited’s Fund Raising Committee has finalised a comprehensive plan to issue non-convertible debentures (NCDs) and commercial papers (CP) to raise a total of Rs 5,000 crore on Monday.

Mankind Pharma Limited announced today its plans to raise up to ₹100,000 crore through the issuance of non-convertible ...

Mankind Pharma Ltd.’s board approved issuing Non-Convertible Debentures and Commercial Papers to raise up to ₹10,000 Crore, ...

Mankind Pharma has been in focus since the company announced the acquisition of Bharat Serums and Vaccines from Advent ...